cbdMD, Inc. (AMEX: YCBD-PA) Stock Competitors & Peer Comparison

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, TAK has a market cap of 55.5B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while TAK trades at $17.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas TAK's P/E ratio is 12.55. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to TAK's ROE of +0.02%. Regarding short-term risk, YCBD-PA is more volatile compared to TAK. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check TAK's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, HLN has a market cap of 44.2B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while HLN trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas HLN's P/E ratio is 25.11. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to HLN's ROE of +0.17%. Regarding short-term risk, YCBD-PA is more volatile compared to HLN. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check HLN's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, TEVA has a market cap of 41.2B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while TEVA trades at $35.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas TEVA's P/E ratio is 12.06. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, YCBD-PA is more volatile compared to TEVA. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check TEVA's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, VTRS has a market cap of 19.1B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while VTRS trades at $16.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas VTRS's P/E ratio is 6.52. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, YCBD-PA is more volatile compared to VTRS. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check VTRS's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ITCI trades at $131.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ITCI's P/E ratio is -180.64. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, YCBD-PA is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ITCI's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while CTLT trades at $63.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas CTLT's P/E ratio is -27.84. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, YCBD-PA is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check CTLT's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ELAN has a market cap of 11B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ELAN trades at $22.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ELAN's P/E ratio is 20.86. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, YCBD-PA is more volatile compared to ELAN. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ELAN's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, RDY has a market cap of 10.2B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while RDY trades at $12.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas RDY's P/E ratio is 20.01. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to RDY's ROE of +0.09%. Regarding short-term risk, YCBD-PA is more volatile compared to RDY. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check RDY's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, LNTH has a market cap of 6.6B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while LNTH trades at $100.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas LNTH's P/E ratio is 16.97. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, YCBD-PA is more volatile compared to LNTH. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check LNTH's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, AMRX has a market cap of 5.8B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while AMRX trades at $18.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas AMRX's P/E ratio is 20.16. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, YCBD-PA is more volatile compared to AMRX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check AMRX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, INDV has a market cap of 4.8B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while INDV trades at $38.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas INDV's P/E ratio is 10.64. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to INDV's ROE of -2.16%. Regarding short-term risk, YCBD-PA is more volatile compared to INDV. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check INDV's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, SUPN has a market cap of 2.8B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while SUPN trades at $47.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas SUPN's P/E ratio is 15.57. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, YCBD-PA is more volatile compared to SUPN. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check SUPN's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, RGC has a market cap of 2.7B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while RGC trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas RGC's P/E ratio is -380.99. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to RGC's ROE of -2.32%. Regarding short-term risk, YCBD-PA is more volatile compared to RGC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check RGC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, BHC has a market cap of 2.3B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while BHC trades at $6.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas BHC's P/E ratio is 1.59. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to BHC's ROE of +0.89%. Regarding short-term risk, YCBD-PA is more volatile compared to BHC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check BHC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while DCPH trades at $25.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas DCPH's P/E ratio is -11.58. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, YCBD-PA is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check DCPH's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, HCM has a market cap of 2.2B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while HCM trades at $12.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas HCM's P/E ratio is 4.69. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to HCM's ROE of +0.01%. Regarding short-term risk, YCBD-PA is more volatile compared to HCM. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check HCM's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while AVDL trades at $21.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, YCBD-PA is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check AVDL's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while EMBCV trades at $33.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas EMBCV's P/E ratio is N/A. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, YCBD-PA is more volatile compared to EMBCV. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check EMBCV's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while DVAX trades at $15.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas DVAX's P/E ratio is -41.89. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, YCBD-PA is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check DVAX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ANIP has a market cap of 1.8B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ANIP trades at $78.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ANIP's P/E ratio is 9.52. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, YCBD-PA is more volatile compared to ANIP. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ANIP's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, PRGO has a market cap of 1.8B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while PRGO trades at $12.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas PRGO's P/E ratio is 5.13. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, YCBD-PA is more volatile compared to PRGO. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check PRGO's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while TARO trades at $42.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas TARO's P/E ratio is 30.05. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to TARO's ROE of +0.03%. Regarding short-term risk, YCBD-PA is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check TARO's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, HROW has a market cap of 1.5B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while HROW trades at $40.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas HROW's P/E ratio is 449.33. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to HROW's ROE of -0.34%. Regarding short-term risk, YCBD-PA is more volatile compared to HROW. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check HROW's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while PAHC trades at $34.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas PAHC's P/E ratio is 11.70. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, YCBD-PA is more volatile compared to PAHC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check PAHC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ALVO has a market cap of 1.3B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ALVO trades at $3.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ALVO's P/E ratio is -11.21. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, YCBD-PA is more volatile compared to ALVO. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ALVO's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ETON has a market cap of 1.2B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ETON trades at $44.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ETON's P/E ratio is -637.14. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ETON's ROE of -0.06%. Regarding short-term risk, YCBD-PA is more volatile compared to ETON. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ETON's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, CRON has a market cap of 1.2B. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while CRON trades at $3.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas CRON's P/E ratio is 29.44. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to CRON's ROE of +0.06%. Regarding short-term risk, YCBD-PA is more volatile compared to CRON. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check CRON's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, PCRX has a market cap of 984.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while PCRX trades at $25.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas PCRX's P/E ratio is 9.62. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, YCBD-PA is more volatile compared to PCRX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check PCRX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, COLL has a market cap of 955.8M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while COLL trades at $29.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas COLL's P/E ratio is 3.70. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to COLL's ROE of +0.16%. Regarding short-term risk, YCBD-PA is more volatile compared to COLL. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check COLL's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while PETQ trades at $30.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas PETQ's P/E ratio is 83.73. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, YCBD-PA is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check PETQ's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, AMPH has a market cap of 916.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while AMPH trades at $20.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas AMPH's P/E ratio is 7.09. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, YCBD-PA is more volatile compared to AMPH. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check AMPH's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, IRWD has a market cap of 711.1M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while IRWD trades at $4.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas IRWD's P/E ratio is 5.54. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, YCBD-PA is more volatile compared to IRWD. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check IRWD's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, EVO has a market cap of 710.5M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while EVO trades at $2.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas EVO's P/E ratio is -2.82. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to EVO's ROE of -0.24%. Regarding short-term risk, YCBD-PA is more volatile compared to EVO. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check EVO's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while BDSI trades at $5.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas BDSI's P/E ratio is 6.82. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, YCBD-PA is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check BDSI's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, TLRY has a market cap of 511.1M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while TLRY trades at $4.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas TLRY's P/E ratio is -7.21. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to TLRY's ROE of -0.08%. Regarding short-term risk, YCBD-PA is more volatile compared to TLRY. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check TLRY's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, EOLS has a market cap of 499.8M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while EOLS trades at $7.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas EOLS's P/E ratio is -24.04. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, YCBD-PA is more volatile compared to EOLS. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check EOLS's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, AQST has a market cap of 494.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while AQST trades at $3.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas AQST's P/E ratio is -6.46. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to AQST's ROE of +1.91%. Regarding short-term risk, YCBD-PA is more volatile compared to AQST. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check AQST's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, KMDA has a market cap of 419.4M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while KMDA trades at $7.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas KMDA's P/E ratio is 20.77. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, YCBD-PA is more volatile compared to KMDA. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check KMDA's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, CGC has a market cap of 409.5M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while CGC trades at $0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas CGC's P/E ratio is -0.58. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to CGC's ROE of -0.31%. Regarding short-term risk, YCBD-PA is more volatile compared to CGC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check CGC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, TKNO has a market cap of 346.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while TKNO trades at $6.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas TKNO's P/E ratio is -20.84. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, YCBD-PA is more volatile compared to TKNO. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check TKNO's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ALIM trades at $5.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ALIM's P/E ratio is 5.28. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, YCBD-PA is more volatile compared to ALIM. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ALIM's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while LNDC trades at $8.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas LNDC's P/E ratio is -4.04. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, YCBD-PA is more volatile compared to LNDC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check LNDC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, EMBC has a market cap of 262.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while EMBC trades at $4.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas EMBC's P/E ratio is 1.70. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, YCBD-PA is more volatile compared to EMBC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check EMBC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ORGO has a market cap of 239.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ORGO trades at $1.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ORGO's P/E ratio is 62.00. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ORGO's ROE of -0.27%. Regarding short-term risk, YCBD-PA is more volatile compared to ORGO. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ORGO's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while TYHT trades at $11.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas TYHT's P/E ratio is -1.61. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, YCBD-PA is more volatile compared to TYHT. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check TYHT's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, SIGA has a market cap of 218.8M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while SIGA trades at $3.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas SIGA's P/E ratio is 11.30. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to SIGA's ROE of -0.02%. Regarding short-term risk, YCBD-PA is more volatile compared to SIGA. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check SIGA's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, LFCR has a market cap of 187.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while LFCR trades at $5.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas LFCR's P/E ratio is -4.68. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to LFCR's ROE of -1.95%. Regarding short-term risk, YCBD-PA is more volatile compared to LFCR. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check LFCR's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ACB has a market cap of 185.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ACB trades at $2.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ACB's P/E ratio is -6.10. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ACB's ROE of -0.21%. Regarding short-term risk, YCBD-PA is more volatile compared to ACB. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ACB's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while REPH trades at $2.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas REPH's P/E ratio is -8.04. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to REPH's ROE of -0.22%. Regarding short-term risk, YCBD-PA is more volatile compared to REPH. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check REPH's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, DERM has a market cap of 177M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while DERM trades at $6.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas DERM's P/E ratio is -17.38. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to DERM's ROE of -0.36%. Regarding short-term risk, YCBD-PA is more volatile compared to DERM. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check DERM's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, CRDL has a market cap of 163.7M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while CRDL trades at $1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas CRDL's P/E ratio is -5.05. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, YCBD-PA is more volatile compared to CRDL. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check CRDL's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while THTX trades at $3.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas THTX's P/E ratio is -28.83. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to THTX's ROE of +0.17%. Regarding short-term risk, YCBD-PA is more volatile compared to THTX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check THTX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ASRT trades at $23.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ASRT's P/E ratio is -7.10. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, YCBD-PA is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ASRT's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, OGI has a market cap of 139.4M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while OGI trades at $0.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas OGI's P/E ratio is -3.81. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to OGI's ROE of -0.07%. Regarding short-term risk, YCBD-PA is more volatile compared to OGI. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check OGI's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, CPIX has a market cap of 116.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while CPIX trades at $7.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas CPIX's P/E ratio is -19.50. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, YCBD-PA is more volatile compared to CPIX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check CPIX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while SCTL trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas SCTL's P/E ratio is -7.86. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, YCBD-PA is more volatile compared to SCTL. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check SCTL's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while PROC trades at $1.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas PROC's P/E ratio is 1.53. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to PROC's ROE of -2.22%. Regarding short-term risk, YCBD-PA is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check PROC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while OPTN trades at $9.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas OPTN's P/E ratio is -4.42. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, YCBD-PA is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check OPTN's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ZOM trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ZOM's P/E ratio is -1.62. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, YCBD-PA is more volatile compared to ZOM. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ZOM's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ZYBT has a market cap of 89.6M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ZYBT trades at $1.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ZYBT's P/E ratio is -8.59. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, YCBD-PA is less volatile compared to ZYBT. This indicates lower risk in terms of short-term price fluctuations for YCBD-PA.Check ZYBT's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while GRVI trades at $4.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas GRVI's P/E ratio is 26.05. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, YCBD-PA is more volatile compared to GRVI. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check GRVI's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ZYNE trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, YCBD-PA is more volatile compared to ZYNE. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ZYNE's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while SSIC trades at $10.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas SSIC's P/E ratio is 11.93. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, YCBD-PA is more volatile compared to SSIC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check SSIC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while VLNS trades at $0.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas VLNS's P/E ratio is -1.03. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to VLNS's ROE of N/A. Regarding short-term risk, YCBD-PA is more volatile compared to VLNS. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check VLNS's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, BGM has a market cap of 60.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while BGM trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas BGM's P/E ratio is -1.04. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to BGM's ROE of -0.07%. Regarding short-term risk, YCBD-PA is more volatile compared to BGM. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check BGM's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while DRRX trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas DRRX's P/E ratio is -4.44. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, YCBD-PA is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check DRRX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, INCR has a market cap of 58M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while INCR trades at $0.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas INCR's P/E ratio is -2.26. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to INCR's ROE of -0.09%. Regarding short-term risk, YCBD-PA is more volatile compared to INCR. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check INCR's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while JUPW trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas JUPW's P/E ratio is -2.41. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, YCBD-PA is more volatile compared to JUPW. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check JUPW's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while QLI trades at $5.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas QLI's P/E ratio is -4.92. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to QLI's ROE of -0.16%. Regarding short-term risk, YCBD-PA is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check QLI's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while HEXO trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas HEXO's P/E ratio is -0.26. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, YCBD-PA is more volatile compared to HEXO. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check HEXO's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, TLPH has a market cap of 29.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while TLPH trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas TLPH's P/E ratio is -4.61. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, YCBD-PA is more volatile compared to TLPH. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check TLPH's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, RMTI has a market cap of 28.5M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while RMTI trades at $7.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas RMTI's P/E ratio is -6.89. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, YCBD-PA is more volatile compared to RMTI. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check RMTI's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, AYTU has a market cap of 25.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while AYTU trades at $2.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas AYTU's P/E ratio is -1.23. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, YCBD-PA is more volatile compared to AYTU. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check AYTU's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, TXMD has a market cap of 24M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while TXMD trades at $2.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas TXMD's P/E ratio is 105.45. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to TXMD's ROE of +0.01%. Regarding short-term risk, YCBD-PA is more volatile compared to TXMD. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check TXMD's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while CYTH trades at $0.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas CYTH's P/E ratio is -0.80. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, YCBD-PA is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check CYTH's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while EVOK trades at $11.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas EVOK's P/E ratio is -7.97. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, YCBD-PA is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check EVOK's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, BFRIW has a market cap of 17M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while BFRIW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas BFRIW's P/E ratio is -0.03. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to BFRIW's ROE of -4.77%. Regarding short-term risk, YCBD-PA is less volatile compared to BFRIW. This indicates lower risk in terms of short-term price fluctuations for YCBD-PA.Check BFRIW's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, OPTH has a market cap of 16.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while OPTH trades at $5.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas OPTH's P/E ratio is -18.56. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to OPTH's ROE of -0.94%. Regarding short-term risk, YCBD-PA is more volatile compared to OPTH. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check OPTH's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ACRX trades at $0.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ACRX's P/E ratio is -0.31. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, YCBD-PA is more volatile compared to ACRX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ACRX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, COSM has a market cap of 12.7M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while COSM trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas COSM's P/E ratio is -0.38. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to COSM's ROE of -0.96%. Regarding short-term risk, YCBD-PA is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check COSM's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while AGRX trades at $1.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas AGRX's P/E ratio is -0.89. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, YCBD-PA is more volatile compared to AGRX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check AGRX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while NLTX trades at $3.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas NLTX's P/E ratio is -0.28. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to NLTX's ROE of -0.38%. Regarding short-term risk, YCBD-PA is more volatile compared to NLTX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check NLTX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while LCI trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas LCI's P/E ratio is -0.04. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to LCI's ROE of +1.66%. Regarding short-term risk, YCBD-PA is more volatile compared to LCI. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check LCI's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ADMP trades at $0.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ADMP's P/E ratio is -0.08. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, YCBD-PA is more volatile compared to ADMP. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ADMP's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, YCBD has a market cap of 5.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while YCBD trades at $0.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas YCBD's P/E ratio is -1.38. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, YCBD-PA is more volatile compared to YCBD. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check YCBD's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, GELS has a market cap of 5M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while GELS trades at $0.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas GELS's P/E ratio is -1.09. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to GELS's ROE of -0.25%. Regarding short-term risk, YCBD-PA is more volatile compared to GELS. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check GELS's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while MNK trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas MNK's P/E ratio is -0.44. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to MNK's ROE of -0.26%. Regarding short-term risk, YCBD-PA is less volatile compared to MNK. This indicates lower risk in terms of short-term price fluctuations for YCBD-PA.Check MNK's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while FLGC trades at $7.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas FLGC's P/E ratio is -0.19. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, YCBD-PA is less volatile compared to FLGC. This indicates lower risk in terms of short-term price fluctuations for YCBD-PA.Check FLGC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, CPHI has a market cap of 3.6M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while CPHI trades at $1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas CPHI's P/E ratio is -1.76. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to CPHI's ROE of -0.19%. Regarding short-term risk, YCBD-PA is more volatile compared to CPHI. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check CPHI's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, UPC has a market cap of 3.5M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while UPC trades at $5.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas UPC's P/E ratio is -0.69. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to UPC's ROE of -0.03%. Regarding short-term risk, YCBD-PA is more volatile compared to UPC. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check UPC's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, SBFM has a market cap of 2.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while SBFM trades at $1.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas SBFM's P/E ratio is -0.20. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to SBFM's ROE of -0.26%. Regarding short-term risk, YCBD-PA is less volatile compared to SBFM. This indicates lower risk in terms of short-term price fluctuations for YCBD-PA.Check SBFM's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, SHPH has a market cap of 2.6M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while SHPH trades at $4.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas SHPH's P/E ratio is -0.20. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to SHPH's ROE of -4.08%. Regarding short-term risk, YCBD-PA is more volatile compared to SHPH. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check SHPH's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while PLXP trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas PLXP's P/E ratio is -0.22. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, YCBD-PA is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for YCBD-PA.Check PLXP's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, SNOA has a market cap of 2.4M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while SNOA trades at $1.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas SNOA's P/E ratio is -1.22. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, YCBD-PA is more volatile compared to SNOA. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check SNOA's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while ATNX trades at $0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas ATNX's P/E ratio is -0.02. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, YCBD-PA is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check ATNX's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, PROCW has a market cap of 2M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while PROCW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas PROCW's P/E ratio is N/A. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, YCBD-PA is more volatile compared to PROCW. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check PROCW's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, RDHL has a market cap of 1.9M. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while RDHL trades at $0.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas RDHL's P/E ratio is 0.12. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to RDHL's ROE of +57.40%. Regarding short-term risk, YCBD-PA is more volatile compared to RDHL. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check RDHL's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, CYTHW has a market cap of 928K. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while CYTHW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas CYTHW's P/E ratio is N/A. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to CYTHW's ROE of -7.30%. Regarding short-term risk, YCBD-PA is more volatile compared to CYTHW. This indicates higher risk in terms of short-term price fluctuations for YCBD-PA.Check CYTHW's competition here

cbdMD, Inc. (AMEX: YCBD-PA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, YCBD-PA stands at 928.2K. In comparison, LSDI has a market cap of 906.9K. Regarding current trading prices, YCBD-PA is priced at $1.35 on the AMEX, while LSDI trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

YCBD-PA currently has a P/E ratio of -2.69, whereas LSDI's P/E ratio is -0.07. In terms of profitability, YCBD-PA's ROE is -0.34%, compared to LSDI's ROE of +181.47%. Regarding short-term risk, YCBD-PA is less volatile compared to LSDI. This indicates lower risk in terms of short-term price fluctuations for YCBD-PA.Check LSDI's competition here